Covered recipient · General Payments record
ANGELA DAWN DUNCAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,570.10
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $870.79 | 36 |
| Education | $99.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $202.66 | 3 |
| Janssen Biotech, Inc. | $114.30 | 5 |
| E.R. Squibb & Sons, L.L.C. | $70.55 | 3 |
| EISAI INC. | $56.93 | 1 |
| Daiichi Sankyo Inc. | $56.66 | 2 |
| Acerta Pharma LLC | $53.79 | 3 |
| GENZYME CORPORATION | $50.84 | 2 |
| Merck Sharp & Dohme Corporation | $46.59 | 2 |
| SOBI, INC | $42.93 | 2 |
| Astellas Pharma US Inc | $30.88 | 1 |
| Tempus AI, Inc | $24.67 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.30 | 1 |
| Stemline Therapeutics Inc. | $22.32 | 1 |
| Kyowa Kirin, Inc. | $20.39 | 1 |
| Genentech USA, Inc. | $19.96 | 1 |
| Janssen Pharmaceuticals, Inc | $19.35 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.01 | 1 |
| Deciphera Pharmaceuticals Inc. | $16.94 | 1 |
| Exelixis Inc. | $16.83 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.02 | 1 |
| ARRAY BIOPHARMA INC | $15.50 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.25 | 1 |
| Currax Pharmaceuticals LLC | $15.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.